Loading video...
Video Failed to Load
DeSci isn’t about DISRUPTING science; it’s about ACCELERATING it. From funding biotech IP to real clinical trials, Bio Protocol is building for the long term. Paul Kohlhaas bio/acc explains why real-world assets matter more than hype cycles. Watch his full interview with Jorge | The Gaming Strategist below 👇
34,166 views • 8 months ago •via X (Twitter)
0 Comments
No comments available
Comments from the original post will appear here



